Last Updated: 12/12/2024

Phase 1 & 2: PATH/GSK collaboration to support adoption of best clinical practices for radical cure of Plasmodium vivax in India

Objectives

The objectives of this project were:

  1. Understand the risks and opportunities associated with access to best clinical practices for managing vivax malaria in India; and
  2. Support adoption of best clinical practices for radical cure of Plasmodium vivax in India.
Principal Institution

PATH, United States

Principal Investigators / Focal Persons

Gonzalo Domingo

Date

Apr 2018 — Oct 2022

Project Site

India

SHARE
SHARE